Update: perinatally acquired HIV/AIDS - United States, 1997
Article Abstract:
Guidelines from the US Public Health Service for identifying and treating HIV-infected pregnant women seem to have reduced the number of infants born with the infection. The guidelines for voluntary testing of pregnant women and zidovudine use in those infected were issued in 1994 and 1995. Since then, 87% of the HIV-infected women detected in 29 states were identified before or at the time of birth. The percentage of infected women given zidovudine increased from 24% to 64% between 1994 and 1996. Although the number of HIV-infected newborns had increased each year since 1984, it dropped 43% between 1992 and 1996.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Trends in Perinatal Transmission of HIV/AIDS in the United States
Article Abstract:
Testing pregnant women for HIV and treating them with zidovudine appears to have caused a dramatic drop in the number of infants with HIV infection. These guidelines were introduced by the US Public Health Service in 1994. Researchers analyzed data from a nationwide AIDS surveillance database and found that the number of newborn infants with AIDS dropped 67% between 1992 and 1997. Since the number of births to HIV-infected women only decreased 17%, most of the decrease in pediatric AIDS cases can be attributed to HIV testing and zidovudine use.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Prenatal Discussion of HIV Testing and Maternal HIV Testing--14 States, 1996-1997
Article Abstract:
More doctors are testing pregnant women for HIV since the US Public Health Service recommended this in July, 1995. Data from the 1997 Pregnancy Risk Assessment Monitoring System (PRAMS) indicates that the percentage of mothers who discussed HIV testing with their prenatal health-care provider ranged from 63.4% in Maine to 86.7% in North Carolina, and the proportion of mothers who were tested ranged from 58.0% in Oklahoma to 80.7% in Florida. Doctors may take a woman's risk factors into account when deciding to recommend HIV testing.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: State-specific variation in rates of twin births - United States, 1992-1994. Contribution of Assisted Reproduction Technology and Ovulation-Inducing Drugs to Triplet and Higher-Order Multiple Births--United States, 1980-1997
- Abstracts: Multidrug-resistant Salmonella serotype typhimurium - United States, 1996. Salmonellosis Associated With Chicks and Ducklings--Michigan and Missouri, Spring 1999
- Abstracts: Rising incidence of hepatocellular carcinoma in the United States. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
- Abstracts: Sexual behavior in the United States, 1930-1990: trends and methodological problems
- Abstracts: Folate intake in Europe: Recommended, actual and desired intake. Prediction of resting energy needs in older men with heart failure